Serum-Free Media Market
Serum-Free Media Market Study by Protein Expression, Stem Cell, Hybridoma, Primary Cell, Insect Cell, Immunology, and Chinese Hamster Ovary Cell Culture Media from 2024 to 2034
Analysis of Serum-Free Media Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Serum-Free Media Market Outlook (2024 to 2034)
The global serum-free media market size is projected to increase from a size of US$ 1.97 billion in 2024 to US$ 4.08 billion by the end of 2034, rising at a CAGR of 7.6% from 2024 to 2034.
Serum is a component derived from animal sources, and serum-free media is part of the biopharmaceutical industry that offers cell culture media without using serum. Serum-free media provide several benefits, including improved cell growth, increased productivity, and a lower risk of contamination.
Serum-free media are widely used in a variety of applications, including biopharmaceutical manufacturing, vaccine development, stem cell research, and regeneration medicine. Some advantages of using serum-free media are media formulation with defined composition, more consistent performance, easier purification, downstream processing, precise evaluations of cellular function, increased growth and/or productivity, better control(s) over physiological responsiveness, and enhanced detection of cellular mediators.
Serum-free media are becoming more effective and high-quality due to new formulations and developments in manufacturing technology. Researchers and manufacturers are constantly working to optimize media compositions to meet the specific needs of different cell types.
Key Market Growth Drivers
- Serum-free media have several advantages over conventional serum-based media. They provide more control over the composition and quality of the culture medium, reducing batch-to-batch variability.
- Serum-free media eliminate the risk of contamination from unknown components in animal serum. These advantages make serum-free media a popular choice among researchers and manufacturers, thus driving market growth.
- Use of serum-free media in biopharmaceutical production is also recommended by regulatory bodies across the globe such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
- Advanced cell culture techniques and bioprocessing technologies are significantly contributing to the growth of the market.
- Chemically defined media formulations and recombinant growth factors are a few such examples of innovations that are improving cell culture system performance and reproducibility.
- These advancements are resulting in increased use of serum-free media in both research laboratories and industrial-scale production, moving the market forward.
| Report Attributes | Details |
|---|---|
| Serum-Free Media Market Size (2024E) | US$ 1.97 Billion |
| Forecasted Market Value (2034F) | US$ 4.08 Billion |
| Global Market Growth Rate (2024 to 2034) | 7.6% CAGR |
| East Asia Market Share (2024E) | 18% |
| North America Market Share (2024E) | 34.7% |
| Biopharmaceutical Production Segment Value (2024E) | US$ 1.65 Billion |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the Key Serum-Free Media Market Trends?
“Advancements in Cell-Based Therapies and Growing Biopharmaceutical Industry”
Increasing demand for biopharmaceuticals is driving the demand for serum-free media. Serum-free media acts as an important factor for developing and manufacturing cell-based therapies, such as stem cell therapies and regenerative medicine. With such innovation in therapies, the demand for serum-free media is projected to increase, thus driving market growth.
With a rise in the number of manufacturers, the biopharmaceutical industry is focusing on the development of biologics, including monoclonal antibodies, recombinant proteins, and vaccines. In a controlled setting, a serum-free medium is also used to create these complex biopharmaceuticals, resulting in uniformity and expansion.
“Shift toward Animal Component-Free Culture Systems”
Animal-derived serum can introduce variability in cell culture systems, resulting in safety concerns. The need for more reliable and standardized cell culture processes is driving the shift towards animal component-free culture systems. The continuation of this trend is providing significant opportunities for market players.
Serum-free medium plays a vital role in tissue engineering, which involves the cultivation of human tissues and organs in the lab for transplantation or research. Advancements in tissue engineering are projected to fuel demand for serum-free media, making it easier to develop functional and viable tissues for various applications.
What are the Limitations of Serum-Free Media?
“Higher Cost of Serum-Free Media and Absence of Essential Components Found in Serum”
Serum-free media come with some disadvantages, including the absence of the complex mixture of growth factors, nutrients, and hormones found in serum, which are essential for cell growth and function. Another disadvantage is the slow growth in comparison to serum-containing media that induce cell growth. Serum-free media necessitates a higher level of reagent purity; therefore, pure-grade reagents and sterile techniques should always be used to ensure greater cell viability. Serum-free media are more expensive in comparison to serum because the chemicals used in the media are expensive and difficult to obtain.
“Compatibility Challenges with Multiple Cell Lines”
A large number of serum-free media are prepared for various cell lines, which causes problems when conducting experiments with multiple cell lines. A separate medium is required even for the same cell line, as a serum-free medium is incompatible with different stages of development.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
North America occupies a significant 35% of the global serum-free media market share in terms of revenue in 2024, and the market in the region is projected to expand significantly over the next few years. East Asia accounts for an 18% share of the global market. The markets in East Asia and North America are projected to expand due to the growing pharmaceutical sector in these regions.
How is the Serum-Free Media Market Faring in the United States?
“Well-Established Healthcare Infrastructure and Rising Demand for Recombinant Proteins”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 547 Million |
| Growth Rate (2024 to 2034) | 6.9% CAGR |
| Projected Value (2034F) | US$ 1.07 Billion |
The United States accounts for 80% share of the North American market in 2024, due to advancements in cell-based assays such as cellular expression, pluripotent stem cell research, and cytotoxicity assay, among others. The market growth is also witnessed primarily due to increased research funding for cell and stem-cell-based products, a large number of CROs, and a well-established healthcare infrastructure.
Other factors, such as the increased use of serum-free media culture to develop vaccines for chronic diseases and the rise in demand for various recombinant proteins are contributing to the country's serum-free media market growth.
Why are Sales of Serum-Free Media Increasing Swiftly in China?
“Increased Investments in Biopharmaceutical Research and Development”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 187 Million |
| Growth Rate (2024 to 2034) | 9.2% CAGR |
| Projected Value (2034F) | US$ 451 Million |
Increased investments in research & development and the expansion of the biopharmaceutical industry in the country are contributing to the expansion of the serum-free media market size. China occupies a 53% share of the East Asia market in 2024.
Category-wise Insights
What is the Reason Behind the High Adoption of CHO Cell Media?
“Higher Efficiency of CHO Cell-Based Biomanufacturing Reducing Production Costs and Timelines”
| Attribute | CHO Cell Media |
|---|---|
| Segment Value (2024E) | US$ 390.2 Million |
| Growth Rate (2024 to 2034) | 9.2% CAGR |
| Projected Value (2034F) | US$ 944.9 Million |
Chinese hamster ovary (CHO) cells are crucial for the growth and production of recombinant proteins in suspension culture. A serum-free medium (SFM) is important for producing recombinant therapeutic proteins (RTPs), and 70% of RTPs are produced by CHO cells. The continued demand for monoclonal antibodies (mAbs) in the pharmaceutical industry is a key driver for the growth of the CHO cell media segment.
CHO cells are essential for the production of mAbs, which are used to treat a variety of diseases, including cancer and autoimmune disorders. The increased adoption of mAb-based therapies, combined with ongoing research and development in this field, is boosting the demand for CHO cells. The market is also benefiting from increased R&D efforts to improve cell line development and bioprocess optimization. These advancements are contributing to the efficiency and productivity of CHO cell-based biomanufacturing, lowering production costs and timelines.
Why are Biopharmaceutical Companies Leading End Users of Serum-Free Media?
“Role of Serum-Free Media in Creating Defined and Controlled Environment for Cell Culture”
| Attribute | Biopharmaceutical Companies |
|---|---|
| Segment Value (2024E) | US$ 1.65 Billion |
| Growth Rate (2024 to 2034) | 7.4% CAGR |
| Projected Value (2034F) | US$ 3.35 Billion |
The biopharmaceutical industry, which also includes monoclonal antibodies, recombinant proteins, and vaccines has gained popularity in recent years as serum-free media are required to produce these biopharmaceuticals. This creates a defined and controlled environment for cell culture. With the increasing demand for biopharmaceuticals, the adoption of serum-free media formulations that ensure optimal cell growth, productivity, and product quality is projected to rise.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Key players in the serum-free media market are Thermo Fisher Scientific Inc., Merck KGaA (known as MilliporeSigma in the United States and Canada), Lonza Group Ltd., Corning Incorporated, GE Healthcare, HiMedia Laboratories, Bio-Rad Laboratories, Inc., Fujifilm Irvine Scientific, Inc., Sartorius AG, and Cytiva (formerly GE Healthcare Life Sciences).
- PromoCell introduced the “PromoExQ MSC Growth Medium XF” for cell therapy manufacturing applications in July 2023. The xeno- and serum-free medium aligns with the company's EXCiPACT GMP certification scheme, optimized for in-vitro expansion of human MSCs in a GMP-regulated environment. It ensures consistent growth and maintenance of various multipotent MSCs.
- In May 2022, FUJIFILM Irvine Scientific established a new bioprocessing innovation and merger center in China. This center is assisting local resources and knowledge in the optimization of cell culture media and processes to facilitate the development of biotherapeutics, advanced therapies, and vaccine production in China.
Segmentation of Serum-Free Media Market Research
-
By Type :
- Protein Expression Media
- Stem Cell Media
- Hybridoma Media
- Primary Cell Media
- Insect Cell Media
- Immunology Media
- Chinese Hamster Ovary Cell Culture Media
-
By End User :
- Biopharmaceutical Companies
- Clinical Research Organizations
- Academic Research Centers
-
By Region :
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Type modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Type USPs /Technology 4.4. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Type launches 5.2.2. Cost of Types 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Volume (Units) Analysis 2018 to 2023 and Forecast, 2024 to 2034 6.1. Historical Market Volume (Units) Analysis, 2018 to 2023 6.2. Current and Future Market Volume (Units) Projections, 2024 to 2034 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Type 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 8. Global Market Value Analysis 2018 to 2023 and Forecast, 2024 to 2034 8.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2023 8.2. Current and Future Market Value (US$ Mn) Projections, 2024 to 2034 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Type, 2018 to 2023 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2024 to 2034 9.3.1. Protein Expression Media 9.3.2. Stem Cell Media 9.3.3. Hybridoma Media 9.3.4. Primary Cell Media 9.3.5. Insect Cell Media 9.3.6. Immunology Media 9.3.7. Chinese Hamster Ovary Cell Culture Media 9.4. Market Attractiveness Analysis By Type 10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by End User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2018 to 2023 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024 to 2034 10.3.1. Biopharmaceutical Companies 10.3.2. Clinical Research Organizations 10.3.3. Academic Research Centers 10.4. Market Attractiveness Analysis By End User 11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2018 to 2023 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. East Asia 11.3.5. South Asia 11.3.6. Oceania 11.3.7. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 12.3.1. By Country 12.3.1.1. U.S. 12.3.1.2. Canada 12.3.2. By Type 12.3.3. By End User 12.4. Market Attractiveness Analysis 12.5. Key Market Participants - Intensity Mapping 12.6. Drivers and Restraints - Impact Analysis 13. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Mexico 13.3.1.3. Argentina 13.3.1.4. Rest of Latin America 13.3.2. By Type 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. Italy 14.3.1.3. France 14.3.1.4. U.K. 14.3.1.5. Spain 14.3.1.6. Russia 14.3.1.7. Rest of Europe 14.3.2. By Type 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. South Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Thailand 15.3.1.3. Indonesia 15.3.1.4. Malaysia 15.3.1.5. Rest of South Asia 15.3.2. By Type 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.1.4. Rest of East Asia 16.3.2. By Type 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Type 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. South Africa 18.3.1.3. Rest of Middle East and Africa 18.3.2. By Type 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.5. Drivers and Restraints - Impact Analysis 19. Key and Emerging Countries Market Analysis 2018 to 2023 and Forecast 2024 to 2034 19.1. Introduction 19.1.1. Market Value Proportion Analysis, By Key Countries 19.1.2. Global Vs. Country Growth Comparison 19.2. U.S. Market Analysis 19.2.1. By Type 19.2.2. By End User 19.3. Canada Market Analysis 19.3.1. By Type 19.3.2. By End User 19.4. Mexico Market Analysis 19.4.1. By Type 19.4.2. By End User 19.5. Brazil Market Analysis 19.5.1. By Type 19.5.2. By End User 19.6. U.K. Market Analysis 19.6.1. By Type 19.6.2. By End User 19.7. Germany Market Analysis 19.7.1. By Type 19.7.2. By End User 19.8. France Market Analysis 19.8.1. By Type 19.8.2. By End User 19.9. Italy Market Analysis 19.9.1. By Type 19.9.2. By End User 19.10. Spain Market Analysis 19.10.1. By Type 19.10.2. By End User 19.11. BENELUX Market Analysis 19.11.1. By Type 19.11.2. By End User 19.12. Russia Market Analysis 19.12.1. By Type 19.12.2. By End User 19.13. China Market Analysis 19.13.1. By Type 19.13.2. By End User 19.14. Japan Market Analysis 19.14.1. By Type 19.14.2. By End User 19.15. South Korea Market Analysis 19.15.1. By Type 19.15.2. By End User 19.16. India Market Analysis 19.16.1. By Type 19.16.2. By End User 19.17. ASEAN Market Analysis 19.17.1. By Type 19.17.2. By End User 19.18. Australia Market Analysis 19.18.1. By Type 19.18.2. By End User 19.19. New Zealand Market Analysis 19.19.1. By Type 19.19.2. By End User 19.20. GCC Countries Market Analysis 19.20.1. By Type 19.20.2. By End User 19.21. Turkey Market Analysis 19.21.1. By Type 19.21.2. By End User 19.22. South Africa Market Analysis 19.22.1. By Type 19.22.2. By End User 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Concentration 20.3. Market Share Analysis of Top Players 20.4. Market Presence Analysis 20.4.1. By Regional footprint of Players 20.4.2. Type foot print by Players 20.4.3. Channel Foot Print by Players 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Benchmarking 21.3. Competition Deep dive 21.3.1. Thermo Fisher Scientific Inc. 21.3.1.1. Overview 21.3.1.2. Type Portfolio 21.3.1.3. Profitability by Market Segments (Type/Channel/Region) 21.3.1.4. Sales Footprint 21.3.1.5. Strategy Overview 21.3.2. Merck KGaA (known as MilliporeSigma in the United States and Canada) 21.3.2.1. Overview 21.3.2.2. Type Portfolio 21.3.2.3. Profitability by Market Segments (Type/Channel/Region) 21.3.2.4. Sales Footprint 21.3.2.5. Strategy Overview 21.3.3. Lonza Group Ltd. 21.3.3.1. Overview 21.3.3.2. Type Portfolio 21.3.3.3. Profitability by Market Segments (Type/Channel/Region) 21.3.3.4. Sales Footprint 21.3.3.5. Strategy Overview 21.3.4. Corning Incorporated 21.3.4.1. Overview 21.3.4.2. Type Portfolio 21.3.4.3. Profitability by Market Segments (Type/Channel/Region) 21.3.4.4. Sales Footprint 21.3.4.5. Strategy Overview 21.3.5. GE Healthcare 21.3.5.1. Overview 21.3.5.2. Type Portfolio 21.3.5.3. Profitability by Market Segments (Type/Channel/Region) 21.3.5.4. Sales Footprint 21.3.5.5. Strategy Overview 21.3.6. HiMedia Laboratories 21.3.6.1. Overview 21.3.6.2. Type Portfolio 21.3.6.3. Profitability by Market Segments (Type/Channel/Region) 21.3.6.4. Sales Footprint 21.3.6.5. Strategy Overview 21.3.7. Bio-Rad Laboratories, Inc. 21.3.7.1. Overview 21.3.7.2. Type Portfolio 21.3.7.3. Profitability by Market Segments (Type/Channel/Region) 21.3.7.4. Sales Footprint 21.3.7.5. Strategy Overview 21.3.8. Fujifilm Irvine Scientific, Inc. 21.3.8.1. Overview 21.3.8.2. Type Portfolio 21.3.8.3. Profitability by Market Segments (Type/Channel/Region) 21.3.8.4. Sales Footprint 21.3.8.5. Strategy Overview 21.3.9. Sartorius AG 21.3.9.1. Overview 21.3.9.2. Type Portfolio 21.3.9.3. Profitability by Market Segments (Type/Channel/Region) 21.3.9.4. Sales Footprint 21.3.9.5. Strategy Overview 21.3.10. Cytiva (formerly GE Healthcare Life Sciences) 21.3.10.1. Overview 21.3.10.2. Type Portfolio 21.3.10.3. Profitability by Market Segments (Type/Channel/Region) 21.3.10.4. Sales Footprint 21.3.10.5. Strategy Overview 22. Assumptions and Acronyms Used 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018 to 2034, By Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 08: Latin America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 11: Europe Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 14: South Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 17: East Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 20: Oceania Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2018 to 2023
Figure 02: Global Market Volume Forecast (in 000' Units), 2024 to 2034
Figure 03: Pricing Analysis (US$) Per Type, By Region, 2023
Figure 04: Pricing Analysis (US$) Per Type, By Region, 2023
Figure 05: Global Market Value Analysis (US$ Mn), 2018 to 2023
Figure 06: Global Market Value Forecast (US$ Mn), 2024 to 2034
Figure 07: Global Market Absolute $ Opportunity, 2024 to 2034
Figure 08: Global Market Share Analysis (%), By Type, 2024 to 2034
Figure 09: Global Market Y-o-Y Analysis (%), By Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Type, 2024 to 2034
Figure 11: Global Market Share Analysis (%), By End User, 2024 to 2034
Figure 12: Global Market Y-o-Y Analysis (%), By End User, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 14: Global Market Share Analysis (%), By Region, 2024 to 2034
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value Share, By Type, 2024 (E)
Figure 18: North America Market Value Share, By End User, 2024 (E)
Figure 19: North America Market Value Share, By Country, 2024 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 21: North America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 22: North America Market Attractiveness Analysis by Type, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 24: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 25: Latin America Market Value Share, By Type, 2024 (E)
Figure 26: Latin America Market Value Share, By End User, 2024 (E)
Figure 27: Latin America Market Value Share, By Country, 2024 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 29: Latin America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 30: Latin America Market Attractiveness Analysis by Type, 2024 to 2034
Figure 31: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 32: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 33: Europe Market Value Share, By Type, 2024 (E)
Figure 34: Europe Market Value Share, By End User, 2024 (E)
Figure 35: Europe Market Value Share, By Country, 2024 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2018 to 2023
Figure 37: Europe Market Value Forecast (US$ Mn), 2024 to 2034
Figure 38: Europe Market Attractiveness Analysis by Type, 2024 to 2034
Figure 39: Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 40: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 41: South Asia Market Value Share, By Type, 2024 (E)
Figure 42: South Asia Market Value Share, By End User, 2024 (E)
Figure 43: South Asia Market Value Share, By Country, 2024 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 45: South Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 46: South Asia Market Attractiveness Analysis by Type, 2024 to 2034
Figure 47: South Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 48: South Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 49: East Asia Market Value Share, By Type, 2024 (E)
Figure 50: East Asia Market Value Share, By End User, 2024 (E)
Figure 51: East Asia Market Value Share, By Country, 2024 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 53: East Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 54: East Asia Market Attractiveness Analysis by Type, 2024 to 2034
Figure 55: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 56: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 57: Oceania Market Value Share, By Type, 2024 (E)
Figure 58: Oceania Market Value Share, By End User, 2024 (E)
Figure 59: Oceania Market Value Share, By Country, 2024 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2018 to 2023
Figure 61: Oceania Market Value Forecast (US$ Mn), 2024 to 2034
Figure 62: Oceania Market Attractiveness Analysis by Type, 2024 to 2034
Figure 63: Oceania Market Attractiveness Analysis by End User, 2024 to 2034
Figure 64: Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 65: Middle East and Africa Market Value Share, By Type, 2024 (E)
Figure 66: Middle East and Africa Market Value Share, By End User, 2024 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2024 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018 to 2023
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2024 to 2034
Figure 70: Middle East and Africa Market Attractiveness Analysis by Type, 2024 to 2034
Figure 71: Middle East and Africa Market Attractiveness Analysis by End User, 2024 to 2034
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: UNITED STATES Market Value Analysis (US$ Mn), 2024 & 2034
Figure 74: UNITED STATES Market Value Share, By Type, 2024 (E)
Figure 75: UNITED STATES Market Value Share, By End User, 2024 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2024 & 2034
Figure 77: Canada Market Value Share, By Type, 2024 (E)
Figure 78: Canada Market Value Share, By End User, 2024 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2024 & 2034
Figure 80: Mexico Market Value Share, By Type, 2024 (E)
Figure 81: Mexico Market Value Share, By End User, 2024 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2024 & 2034
Figure 83: Brazil Market Value Share, By Type, 2024 (E)
Figure 84: Brazil Market Value Share, By End User, 2024 (E)
Figure 85: UNITED KINGDOM Market Value Analysis (US$ Mn), 2024 & 2034
Figure 86: UNITED KINGDOM Market Value Share, By Type, 2024 (E)
Figure 87: UNITED KINGDOM Market Value Share, By End User, 2024 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2024 & 2034
Figure 89: Germany Market Value Share, By Type, 2024 (E)
Figure 90: Germany Market Value Share, By End User, 2024 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2024 & 2034
Figure 92: France Market Value Share, By Type, 2024 (E)
Figure 93: France Market Value Share, By End User, 2024 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2024 & 2034
Figure 95: Italy Market Value Share, By Type, 2024 (E)
Figure 96: Italy Market Value Share, By End User, 2024 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2024 & 2034
Figure 98: Spain Market Value Share, By Type, 2024 (E)
Figure 99: Spain Market Value Share, By End User, 2024 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 101: Russia Market Value Share, By Type, 2024 (E)
Figure 102: Russia Market Value Share, By End User, 2024 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2024 & 2034
Figure 104: China Market Value Share, By Type, 2024 (E)
Figure 105: China Market Value Share, By End User, 2024 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2024 & 2034
Figure 107: Japan Market Value Share, By Type, 2024 (E)
Figure 108: Japan Market Value Share, By End User, 2024 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2024 & 2034
Figure 110: South Korea Market Value Share, By Type, 2024 (E)
Figure 111: South Korea Market Value Share, By End User, 2024 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2024 & 2034
Figure 113: India Market Value Share, By Type, 2024 (E)
Figure 114: India Market Value Share, By End User, 2024 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2024 & 2034
Figure 116: ASEAN Market Value Share, By Type, 2024 (E)
Figure 117: ASEAN Market Value Share, By End User, 2024 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 119: Australia Market Value Share, By Type, 2024 (E)
Figure 120: Australia Market Value Share, By End User, 2024 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2024 & 2034
Figure 122: New Zealand Market Value Share, By Type, 2024 (E)
Figure 123: New Zealand Market Value Share, By End User, 2024 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2024 & 2034
Figure 125: GCC Countries Market Value Share, By Type, 2024 (E)
Figure 126: GCC Countries Market Value Share, By End User, 2024 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2024 & 2034
Figure 128: Turkey Market Value Share, By Type, 2024 (E)
Figure 129: Turkey Market Value Share, By End User, 2024 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2024 & 2034
Figure 131: South Africa Market Value Share, By Type, 2024 (E)
Figure 132: South Africa Market Value Share, By End User, 2024 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the serum-free media market size in 2024?
The global serum-free media market is estimated at US$ 1.97 billion in 2024.
Which country is a key market for serum-free media?
The United States is estimated at a market valuation of US$ 547 million in 2024.
What is the estimated market size for Japan in 2024?
The market in Japan is forecasted to reach US$ 132 million in 2024.
Which type of serum-free media holds a significant market share?
Chinese hamster ovary (CHO) cells account for a market share of 19.8% in 2024.
What value does the biopharmaceutical companies segment stand at?
The biopharmaceutical companies segment is set to reach US$ 1.65 billion in 2024.
What is the market value of protein type serum-free media?
The market for protein serum-free media is estimated at US$ 381.2 million in 2024.
Serum-Free Media Market